<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Engrossed-in-House" dms-id="H131AE4224EEC44A99928C14D24B0A34D" public-private="public" key="H" bill-type="olc" stage-count="1">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 4424 EH: Vietnam Veterans Liver Fluke Cancer Study Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date></dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="no">IB</distribution-code>
<congress display="yes">118th CONGRESS</congress><session display="yes">2d Session</session>
<legis-num display="yes">H. R. 4424</legis-num>
<current-chamber display="no">IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<legis-type>AN ACT</legis-type>
<official-title display="yes">To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.</official-title>
</form>
<legis-body display-enacting-clause="yes-display-enacting-clause" style="OLC" id="H2201565CCE64467BADB53A0062017D7F">
<section id="H982AC4F7FF424869B68140C0445D4F6A" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Vietnam Veterans Liver Fluke Cancer Study Act</short-title></quote>.</text></section> <section id="H4A083144554D432B8EBDF2B593AFFE4A"><enum>2.</enum><header>Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era</header> <subsection id="HF452D5A5CF3E454CBC206DFF998D3803"><enum>(a)</enum><header>Epidemiological study</header><text display-inline="yes-display-inline">Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall—</text>
<paragraph id="H25D59F3C0AC4496D84390416DAEC3849"><enum>(1)</enum><text display-inline="yes-display-inline">identify the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and</text></paragraph> <paragraph id="HE03128532E924D70BF81BD49E99FC691"><enum>(2)</enum><text>for each of the groups specified in paragraph (1), identify the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis.</text></paragraph></subsection>
<subsection id="H83A1927C213D446083A94DA3A843D351"><enum>(b)</enum><header>Report to Congress</header><text display-inline="yes-display-inline">Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing—</text> <paragraph id="H083093CE02554F0C9C8B2796C0CDE40C"><enum>(1)</enum><text>the results of the study under subsection (a); and</text></paragraph>
<paragraph id="H8BBE717F555C478DA1FA4DB889D3C0E8"><enum>(2)</enum><text>recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a).</text></paragraph></subsection> <subsection id="H2D394D7637C742F58A161E8F3602F674"><enum>(c)</enum><header>Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam era</header><text display-inline="yes-display-inline">The Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress as required under subsection (d).</text></subsection>
<subsection id="H9B543931EAF8424292C78703F03AC66E"><enum>(d)</enum><header>Follow-Up reports</header><text display-inline="yes-display-inline">The Secretary shall periodically submit to the Congress an updated report under subsection (b), as determined by the Secretary.</text></subsection> <subsection id="H913F62A17FC8491F83180751DD97DB9F"><enum>(e)</enum><header>Definitions</header><text>In this section:</text>
<paragraph id="HA16A4531786B48FEB21F91AEF2E41D3B"><enum>(1)</enum><text>The term <quote>Secretary</quote> means the Secretary of Veterans Affairs.</text></paragraph> <paragraph id="H4FDCF88430644098928E78A14EBCCF93"><enum>(2)</enum><text>The term <quote>Vietnam era</quote> has the meaning given such term in section 101 of title 38, United States Code.</text></paragraph>
<paragraph id="H2DFCF4CC439C45078C91D158A38403CB"><enum>(3)</enum><text display-inline="yes-display-inline">The term <quote>covered veterans of the Vietnam era</quote> means veterans who served in the Vietnam theater of operations during the Vietnam era.</text></paragraph></subsection></section> <section id="H8C01ABEA97C74804A66F497F68499D17"><enum>3.</enum><header>Modification of certain housing loan fees</header><text display-inline="no-display-inline">The loan fee table in section 3729(b)(2) of title 38, United States Code, is amended by striking <quote>November 15, 2031</quote> each place it appears and inserting <quote>November 29, 2031</quote>. </text></section>
</legis-body><attestation><attestation-group><attestation-date date="20240917" chamber="House">Passed the House of Representatives September 17, 2024.</attestation-date><attestor display="no">Kevin F. McCumber,</attestor><role>Clerk.</role></attestation-group></attestation>
<endorsement display="yes"></endorsement>
</bill> 


